Skip to content
Try Mental Wellness – Lifestyle
Author:
4basebio
4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial
May 20, 2026
Final Results and Notice of AGM
May 20, 2026
4basebio Announces Appointment of Chief Financial Officer and Board Changes
May 14, 2026
4basebio Launches Enzymatic ssDNA Platform
May 11, 2026
4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility in Cambridge, UK
March 31, 2026